COLOGNE, Germany, May 2, 2023 /PRNewswire/ — Avenga, a global digital engineering and consulting platform, is expanding its presence in the US to support pharmaceutical and biotech companies in seizing the opportunities of digitization. With an extensive service portfolio, Avenga plans, manages, and implements industry-specific digital transformation projects. The company’s service spectrum spans from developing HCP/patient portals to data analytics and reporting hubs to custom software development powered by tailor-made AI algorithms across the value chain, such as commercialization, marketing, R&D, clinical trials, pharmacovigilance, and manufacturing, amongst others. Continue Reading Avenga’s solutions foster streamlined operations and data-driven decision-making, enabling its clients to thrive in the digital age and stay ahead of their competition. " Digital transformation holds tremendous potential for the life sciences and biopharma industries. Through managing complex processes and handling large data sets, technology has opened doors, for instance, for personalized medicine and omnichannel customer engagement. At Avenga, we leverage our expertise to help organizations efficiently analyze and manage their data. As a result, our solutions foster streamlined operations and data-driven decision-making, enabling our clients to thrive in the digital age and stay ahead of their competition ," says Yuriy Adamchuk, CEO of Avenga. Impressive industry expertise […]
Avenga Strengthens US Presence to Drive Digital Transformation in Life Sciences
You may also like...
